NASTAD Announces 2018-2019 Board of Directors

By Kyle Taylor May 31, 2018

FOR IMMEDIATE RELEASE
May 31, 2018

CONTACT: Kyle Taylor
ktaylor@nastad.org | 202.434.7134

NASTAD Announces 2018-2019 Board of Directors

Washington, DC - Last week, NASTAD, a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world, announced its 2018-2019 Board of Directors. NASTAD is governed by a 23-member, elected Board charged with making policy and program decisions on behalf of the full membership.
 
The 2018-2019 Board of Directors includes:
 
Officers (Executive Committee)
Jacquelyn Clymore, North Carolina, Chair
Johanne Morne, New York, Chair-Elect
Jeffrey Hitt, Maryland, Vice-Chair
Michael Kharfen, District of Columbia, Secretary-Treasurer 
DeAnn Gruber, Louisiana, Immediate Past-Chair (ex-officio)
 
Board Members
Sharon Jordan, Alabama
Susan Jones, Alaska
John Sapero, Arizona
Karen Mark, California
Dave Kern, Chicago
William Lyons, Georgia
Peter Whiticar, Hawaii
Marlene McNeese, Houston
Aimee Shipman, Idaho
Eduardo Alvarado, Illinois
Randy Mayer, Iowa
Dawn Fukuda, Massachusetts
James Stewart, Mississippi
Andrew Gans, New Mexico
Demetre Daskalakis, New York City
Jan Fox, Oklahoma
Tracey Packer, San Francisco
Beth Crutsinger-Perry, Washington
 
Executive Director
Murray C. Penner (ex-officio)
 
“It is my pleasure to welcome the 2018-2019 Board of Directors,” said Murray Penner, NASTAD Executive Director. “I look forward to a productive and eventful year as we work together under the guidance of our Board Chair’s Challenge: Achieving Health Equity to End the Epidemics. By strengthening partnerships, promoting leadership, and eliminating stigma and discrimination, we can end the HIV and hepatitis epidemics.”

About NASTAD

Founded in 1992, NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening domestic and global governmental public health through advocacy, capacity building, and social justice.

###